Who invested in LYNK Pharmaceuticals?
LYNK Pharmaceuticals's investors include Legend Capital and Lilly Asia Ventures.
Who invested in LYNK Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$17Mraised across 1 round since 2023, from 1 source
- Latest round
- Series C, $17MSept 2023
- Investors
- 2
The rounds
- Sept 2023
Everyone who backed them
Lilly Asia VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about LYNK Pharmaceuticals
How much has LYNK Pharmaceuticals raised?
LYNK Pharmaceuticals has raised $17M across 1 round since 2023.
When did LYNK Pharmaceuticals last raise?
LYNK Pharmaceuticals's most recent round was a Series C of $17M in Sept 2023.
What was LYNK Pharmaceuticals's biggest round?
Its most recent round, $17M in Sept 2023, is also its largest on record.
Who backed LYNK Pharmaceuticals first?
LYNK Pharmaceuticals's first round on record, in Sept 2023, was backed by Legend Capital and Lilly Asia Ventures.
What stage is LYNK Pharmaceuticals at?
LYNK Pharmaceuticals's latest named round is a Series C, in Sept 2023.
Companies like LYNK Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.